UHPLC-UV Determination of Paroxetine Degradation Products
For determination of paroxetine drug substance and N-methyl paroxetine impurity, supplementary analytical method, running on Acquity UPLC system (Waters Corp., Milford, MA, US) was used (results in 3.1. PEG incompatibility stress test: paroxetin•HCl). A reverse phase column Acquity BEH C18, (100 × 2.1 mm; 1.7 μm, Waters Corp., Milford, MA, USA) and a gradient elution were employed to achieve chromatographic separation. Mobile phase A consisted of ammonium buffer with pH 10.25 and mobile phase B contained water:acetonitrile, 10:90 (v/v). Gradient program was as follows: 35%B (0-0.5 min), 35%-45%B (0.5-7min), 45%-75%B (7-9min), 75%B (9-10.5 min), 75%-35% (10.5-11min). After each run, re-equilibration to initial conditions was performed. The mobile phase flow rate was 0.55 mL/min. Autosampler and column temperatures were set at 5 °C and 40 °C, respectively. The injection volume was 7 μL. Data was recorded by photo diode array (PDA) detector at a wavelength of 295 nm. Aged samples of paroxetine•HCl alone or as mixtures with excipients in glass vials were dissolved in 50 mL of solvent (mixture of acetonitrile, methanol and acetic buffer, pH 4.5). Solutions were sonicated and filtered prior to injection. Results were calculated as area % of N-methyl paroxetine against paroxetine.
Characterization of standards

NMR Measurement Data (Chemical Shifts and Coupling Constants) for Synthesized Standards
2.1.1 N-Formyl Paroxetine 1 H NMR (399 MHz, Chloroform-d) δ 7.36 (d, J = 7.8 Hz, 1H), 7.16 (d, J = 1.8 Hz, 1H), 7.09 (dd, J = 5.0, 1.2 Hz, 2H), 7.04 (dd, J = 7.6, 2.0 Hz, 1H), 6.95 -6.84 (m, 1H), 6.54 -6.47 (m, 1H), 3.34 -3.19 (m, 4H), 3.01 (s, 4H), 2.68 (s, 3H), 2.36 (s, 3H), 2.31 (s, 3H). 13 C NMR (100 MHz, Chloroform-d) δ 147. 77, 142.39, 139.47, 136.18, 134.49, 131.75, 127.89, 127.34, 126.14, 125.66, 125.09, 120.14, 55.42, 50.13, 45.36, 21.19, 20.58. 2.1.3 . N-Methyl saxagliptin 1 H NMR (399 MHz, Methanol-d4) δ 5.48 (s, 0H), 5.18 -4.98 (m, 1H), 3.96 -3.75 (m, 1H), 3.58 (s, 0H), 3.37 (s, 1H), 3.23 (d, J = 3.2 Hz, 0H), 2.70 -2.54 (m, 1H), 2.37 -2.27 (m, 1H), 2.26 (s, 2H), 2.24 -2.12 (m, 2H), 2.03 -1.74 (m, 4H), 1.72 -1.63 (m, 4H), 1.63 -1.53 (m, 3H), 1.52 -1.41 (m, 3H), 1.18 -1.10 (m, 2H), 1.10 -1.01 (m, 1H), 0.98 -0.89 (m, 1H). 13 C NMR (100 MHz, cd3od) δ 174. 55, 174.36, 120.88, 120.85, 70.53, 69.23, 69.16, 61.23, 47.30, 46.74, 46.53, 46.39, 45.40, 45.37, 45.30, 45.26, 42.20, 41.92, 39.19, 38.98, 38.78, 38.72, 38.61, 38.25, 36.65, 36.60, 35.21, 31.90, 31.85, 31.79, 31.77, 31.48, 31.46, 18.85, 18.76, 14.11, 14 .00. Figure S1 . IR spectrum of paroxetine N-formyl impurity. 
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